CHAMPION‑AF Decoded: Watchman Flex vs DOACs
from The IC Chat Hosted by asper1971
In this episode of ICChat, Dr. Ashish Pershad MD MS reviews and critiques the CHAMPION‑AF trial comparing Watchman Flex left atrial appendage occlusion to DOACs for atrial fibrillation. He explains the trial design, endpoints, and statistical choices, and contrasts the published results with real‑world implications. The episode highlights concerns about non‑inferiority margins, excluded procedural bleeding, lower than expected event rates, and the importance of shared decision making when considering LAAO versus lifelong anticoagulation.
Embed this episode
Chapters
- 0:00 Welcome & Podcast Introduction
- 0:43 Podcast Mission & Host Background
- 1:14 Episode Focus: CHAMPION‑AF
- 1:31 Trial Overview: LAAO vs DOACs
- 1:47 Background Debate & Recent Trials (CLOSURE‑AF, AMULET)
- 4:56 CHAMPION‑AF Design: Enrollment, Sites, Eligibility
- 5:46 Randomization, Post‑Procedure Anticoagulation & Endpoints
- 7:01 Statistics & Non‑Inferiority Design Considerations
- 9:06 Critique of Trial Design and Potential Biases
- 11:12 Interview Announcement: Dr. Saigal Kaur
- 11:20 Results — Enrollment, Baseline Characteristics
- 11:59 Primary Efficacy Results & Non‑Inferiority Analysis
- 14:19 Safety Results: Bleeding, Procedural Complications
- 15:57 Overall Interpretation & Clinical Takeaways
- 18:32 Closing, Disclaimers & Outro
No transcript yet.